New & Featured | Dengue Academy

Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda

This website is intended for informational purposes only and is not a substitute for healthcare professional’s clinical knowledge or professional judgment.

© Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2023

New & Featured

Keynote Address: Dengue and Global Health Summary

ADS

16 minutes
Dengue without warning signs: Outpatient management in the public and private setting

ADS

22 minutes
Mass Vaccination During the 2024 Dengue Outbreak in Brazil

ADS

27 minutes
Dengue Immunity: Lessons from clinical trials

ADS

17 minutes
Clinical Management of Dengue with Warning Signs

ADS

23 minutes
The Current Dengue Therapeutics Guideline and How to Deliver Effective Treatment

ADS

12 minutes
Best Practice in Dengue in patient management

ADS

18 minutes
Ideal Dengue Vaccine Characteristics

Medscape
Dengue Immunization: Special Populations

Medscape
Dengue: Vaccinating Travelers to Endemic Regions

Medscape
Dengue Prevention: Integrating Vaccination Into Comprehensive Control Strategies Across Populations

Medscape
Integrated Dengue Management

Takeda

2 minutes
Climate Change and Dengue

Takeda

1 minutes
Risk Factors for Severe Dengue

Takeda

2 minutes
Global Epidemiology 2025

Takeda

3 minutes

Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda

This website is intended for informational purposes only and is not a substitute for healthcare professional’s clinical knowledge or professional judgment.